Outcome prediction in adult core binding factor (CBF) acute myeloid leukemia (AML) with gene expression profiling: A Cancer and Leukemia Group B (CALGB) study

被引：5
|
作者：
Paschka, P.
Radmacher, M. D.
Marcucci, G.
Ruppert, A. S.
Vukosavljevic, T.
Whitman, S. P.
Mrozek, K.
Liu, C.
Larson, R. A.
Bloomfield, C. D.
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Canc & Leukemia Grp B, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
10.1200/JCO.2007.25.18_SUPPL.7011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7011
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mutations of KIT tyrosine kinase (TK) gene predict relapse in adult patients (pts) with core binding factor acute myeloid leukemia (CBF AML):: A Cancer and Leukemia Group B (CALGB) study.
    Paschka, P.
    Marcucci, G.
    Ruppert, A. S.
    Mrózek, K.
    Chen, H.
    Kittles, R. A.
    Vukosavljevic, T.
    Perrotti, D.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 1S - 1S
  • [2] Clinicopathologic Characteristics and Outcome of Acute Myeloid Leukemia with (AML) with Core Binding Factor (CBF) Rearrangements: A Retrospective Study
    Mohamed, Shehab Fareed
    Mulikandathil, Yahya
    Soliman, Dina Sameh
    Abbas, Feryal
    Alshurafa, Awni
    Afana, Mohammad
    Ellahie, Anil Yousaf
    Mudawi, Deena Sideeg
    El Omri, Halima
    Gameil, Amna
    Abuasab, Tareq
    Haddad, Fadi
    Singh, Kalpana
    Kassem, Nancy
    Cherif, Honar
    BLOOD, 2022, 140 : 11651 - 11652
  • [3] Racial differences in prognostic factors and outcome in acute myeloid leukemia (AML): A cancer and leukemia group B (CALGB) study.
    Sekeres, MA
    Dodge, RK
    Bloomfield, CD
    Larson, RA
    Stone, RM
    BLOOD, 2002, 100 (11) : 88A - 88A
  • [4] Overexpression of the ERG gene is an adverse prognostic factor in acute myeloid leukemia (AML) with normal cytogenetics (NC):: A cancer and leukemia group B study (CALGB).
    Marcucci, G
    Baldus, CD
    Ruppert, AS
    Radmacher, MD
    Mrózek, K
    Whitman, SP
    Kolitz, JE
    Edwards, CG
    Vardiman, J
    Powell, BL
    Baer, MR
    Moore, JO
    Perrotti, D
    Caligiuri, MA
    Carroll, AJ
    Larson, RA
    de la Chapelle, A
    Bloomfield, CD
    BLOOD, 2005, 106 (11) : 101A - 101A
  • [5] The clinical spectrum of adult acute myeloid leukemia (AML) associated with core binding factor (CBF) translocations.
    Appelbaum, FR
    Kopecky, KJ
    Slovak, ML
    Gundacker, HM
    Tallman, M
    Kim, H
    Dewald, GW
    Estey, E
    Kantarjian, H
    Pierce, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 563S - 563S
  • [6] Molecular Characterization of Relapsed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Agrawal, Mridul
    Corbacioglu, Andrea
    Jahn, Nikolaus
    Bullinger, Lars
    Teleanu, Maria-Veronica
    Gaidzik, Verena I.
    Weber, Daniela
    Goehring, Gudrun
    Luebbert, Michael
    Fiedler, Walter
    Brossart, Peter
    Kindler, Thomas
    Radsak, Markus
    Ringhoffer, Mark
    Goetze, Katharina S.
    Greil, Richard
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Schlenk, Richard F.
    Doehner, Hartmut
    Paschka, Peter
    Doehner, Konstanze
    BLOOD, 2015, 126 (23)
  • [7] Low Meningioma 1 (MN1) gene expression to predict outcome in cytogenetically normal acute myeloid leukemia (CN-AML): A Cancer and Leukemia Group B (CALGB) study
    Langer, C.
    Maharry, K.
    Mrozek, K.
    Paschka, P.
    Whitman, S. P.
    Kolitz, J. E.
    Larson, R. A.
    Marcucci, G.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Core binding factor acute myeloid leukemia (CBF-AML) in Mexico: A single institution experience
    Ruiz-Delgado, Guillermo J.
    Macias-Gallardo, Julio
    Lutz-Presno, Julia
    Garces-Eisele, Javier
    Hernandez-Arizpe, Ana
    Montes-Montiel, Maryel
    Ruiz-Argueelles, Guillermo J.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (01): : 25 - 30
  • [9] MicroRNA (miR) expression signatures in molecular subsets of cytogenetically normal (CN) acute myeloid leukemia (AML): A Cancer and Leukemia Group B (CALGB) study
    Radmacher, M. D.
    Marcucci, G.
    Paschka, P.
    Vukosavljevic, T.
    Whitman, S. P.
    Ruppert, A. S.
    Mrozek, K.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Mutational Landscape of Relapsed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Dolnik, Anna
    Jahn, Nikolaus
    Strang, Eric
    Cocciardi, Sibylle
    Rucker, Frank G.
    Panina, Ekaterina
    Blatte, Tamara J.
    Herzig, Julia Katharina
    Corbacioglu, Andrea
    Weber, Daniela
    Schrade, Anika
    Gaidzik, Verena I.
    Skambraks, Sabrina
    Gotze, Katharina S.
    Luebbert, Michael
    Fiedler, Walter
    Schroeder, Thomas
    Hahn, Corinna
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Paschka, Peter
    Dohner, Hartmut
    Dohner, Konstanze
    Bullinger, Lars
    BLOOD, 2020, 136
12345